Ms. Richo retired from Cargill, Inc., where she was the General Counsel, Chief Compliance Officer, and Corporate Secretary since 2019.  In addition to her global responsibilities for law and compliance, she oversaw Global Government Relations, Global Security and Shareholder Relations, and was a member of Cargill's Executive Team.  With a law career spanning more than 35 years, Anna wore multiple hats and has extensive experience in compliance and business ethics, intellectual property and corporate litigation.

Prior to joining Cargill, Ms. Richo was Executive Vice President and General Counsel at UCB, a biopharmaceutical company based in Belgium, where she resided for many years. She also served as Senior Vice President and Chief Compliance Officer at Amgen, a global biotechnology firm, and as Chief Litigation Counsel, Associate General Counsel and Vice President of Law at Baxter Healthcare. Her broad international experience extends throughout Europe, Latin America and Asia and has served to strengthen her commitment to championing diversity, equity, and inclusion in the workplace.

Ms. Richo is a member of the Board of Directors of Illumina, Inc., a global human genomics DNA sequencing company, a member of the Board of Trustees of DePaul University, and is a member of the Board of Directors of Children’s Minnesota.  Anna formerly served on the Board of Directors of Adamas Pharmaceuticals, a publicly traded neurology company, from 2020-2021, subsequently acquired by Supernus Pharmaceuticals, and on the Board of Cytyc Corporation, a medical diagnostics company, subsequently acquired by Hologic, Inc.

Ms. Richo received her Bachelor of Science degree in industrial and labor relations from Cornell University and a Juris Doctor degree from DePaul University, College of Law.